跳至主要内容
临床试验/TCTR20210906001
TCTR20210906001招募中不适用

Hypothyroidism in Hb E/Beta-thalassemia children receiving regular transfusion vs underwent HSCT

none0 个研究点目标入组 50 人开始时间: 2021年9月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
1 Years 至 25 Years(—)
性别
All

入选标准

  • 1. Hb E/Beta-thalassemia patients who received regular blood transfusion for >1 year before enrollment in the study
  • 2. Hb E/Beta-thalassemia patients who underwent allogeneic HSCT from October, 2003 to March, 2019 and were followed up >1 year before enrollment in the study and recovered completely without transfusion dependence

排除标准

  • 1.Patients who had abnormal TFT before diagnosis with severe Hb E/Beta-thalassemia
  • 2.Patients who had thyroid function test done less than twice during treatment
  • 3.Patients who were treated with HSCT more than one time

研究者

发起方
none

相似试验